MLAB vs NOVT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

MLAB

33.7
AI Score
VS
NOVT Wins

NOVT

44.2
AI Score

Investment Advisor Scores

MLAB

34score
Recommendation
SELL

NOVT

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MLAB NOVT Winner
Revenue 60.14M 523.51M NOVT
Net Income 2.83M 33.64M NOVT
Gross Margin 64.9% 44.8% MLAB
Net Margin 4.7% 6.4% NOVT
Operating Income 7.03M 45.60M NOVT
ROE 1.5% 2.1% NOVT
ROA 0.7% 1.6% NOVT
Total Assets 419.22M 2.14B NOVT
Cash 30.70M 718.65M NOVT
Debt/Equity 0.35 0.12 NOVT
Current Ratio 1.79 4.57 NOVT
Free Cash Flow 14.18M 104.94M NOVT

Relative Price Performance (Last 90 Days)

MLAB 1M: +23.6% · 3M: +14.3% NOVT 1M: +1.4% · 3M: -6.2%

Current Technical Phase

MLAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.2% over 20 days), RSI 72

RSI (14): 71.7 · Price: $124.76

NOVT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 41

RSI (14): 40.7 · Price: $145.24

Fundamentals Snapshot

Metric MLAB NOVT
Market Cap
Forward P/E 23.2 33.3
Trailing P/E 140.2 92.7
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.6% 0.4%
Operating Margin 0.1% 0.1%
EPS 0.85 1.57
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, NOVT is currently the stronger investment candidate, winning 11 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.